An announcement from Jiangxi Rimag Group Co., Ltd. Class H ( (HK:2522) ) is now available. Jiangxi Rimag Group Co., Ltd. has announced the launch of the world’s first AI-assisted diagnostic product, ...
Abbott’s strong Q3, global diversification, and resilient portfolio support long-term growth despite diagnostics softness and ...
GlobalData on MSN
Abbott’s strong Q3 medtech performance offset by diagnostic weakness
Abbott has reaffirmed its FY25 guidance despite Q3 revenues falling short of analyst expectations, with strong performance ...
Danaher Corporation’s DHR Diagnostics segment continues to contribute steadily to its overall performance. The segment’s core revenues increased 2% on a year-over-year basis in the second quarter of ...
(Reuters) -Revvity on Monday lowered its full-year adjusted profit forecast as it expects demand for diagnostics products in its key market China to be hurt by changes to the country's reimbursement ...
Revvity Inc. (NYSE:RVTY) stock is trading lower on Monday following the life science tools maker’s second-quarter 2025 earnings report, which also included a trimmed profit forecast for 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results